Advanced Practice Midwife in Waconia, MN Accepting Medicare

4 Advanced Practice Midwife nurses found. Showing 1 - 4

Sarah Rose Labine, APRN, CNM Advanced Practice Midwife Medicare: Medicare Enrolled Practice Location: 560 S Maple St Ste 130, Waconia, MN 55387 Phone: 952-442-2191

Mrs. Shawn Johnson, MSN CNM Advanced Practice Midwife Medicare: Accepting Medicare Assignments Practice Location: 560 S Maple St, Suite 130, Waconia, MN 55387 Phone: 952-442-2137

Krista D Kranz, CNM Advanced Practice Midwife Medicare: Medicare Enrolled Practice Location: 500 S Maple St, Waconia, MN 55387 Phone: 952-442-2191

Mrs. Leah Schroeder, CNM Advanced Practice Midwife Medicare: Medicare Enrolled Practice Location: 560 S Maple St Ste 130, Waconia, MN 55387 Phone: 952-442-2137

News Archive

Sialic acid may play significant role in certain brain disorders

A new report published in the July 2015 issue of The FASEB Journal suggests that a common molecule found in higher animals, including humans, affects brain structure. This molecule may play a significant role in how brain cells communicate, possibly shedding light on the underlying causes of certain brain disorders.

Penn researcher finds high recidivism rate is due to few transitional services for ex-offenders

The lack of organized transitional services often leads ex-convicts straight back into the prison system, according to a researcher from the University of Pennsylvania's School of Social Policy and Practice.

Virginia Tech student receives NSERC award to develop minimally invasive treatment for glioblastoma

The Natural Sciences and Engineering Research Council of Canada (NSERC) supports research that results in "breakthrough answers to timeless questions." When choosing awardees, the council looks for creativity and innovation, two qualities they see at the heart of all research advances.

White House unveils finalized health care price transparency rule

Hospitals will soon have to share price information they have long kept obscured — including how big a discount they offer cash-paying patients and rates negotiated with insurers — under a rule finalized Friday by the Trump administration.

Ardea Biosciences' revenues total $8.3M for three months ended December 31, 2009

Ardea Biosciences, Inc. (Nasdaq: RDEA) a biotechnology company focused on the development of small-molecule therapeutics for the treatment of gout, cancer and human immunodeficiency virus (HIV), reported recent accomplishments, announced fourth quarter and full-year 2009 financial results and provided key upcoming clinical development milestones and financial guidance for 2010.

Read more Medical News

› Verified 1 days ago